Procyon Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.74M Sell
30,495
-745
-2% -$174K 0.33% 68
2026
Q1
$7.64M Sell
31,240
-463
-1% -$108K 0.37% 58
2025
Q4
$6.56M Sell
31,703
-10,836
-25% -$2.14M 0.32% 72
2025
Q3
$7.89M Sell
42,539
-2,007
-5% -$344K 0.47% 54
2025
Q2
$6.8M Sell
44,546
-18,448
-29% -$2.84M 0.64% 42
2025
Q1
$10.3M Buy
62,994
+8,048
+15% +$1.26M 0.62% 36
2024
Q4
$7.95M Sell
54,946
-1,263
-2% -$196K 0.5% 44
2024
Q3
$9.11M Buy
56,209
+2,174
+4% +$346K 0.62% 39
2024
Q2
$7.9M Buy
54,035
+345
+0.6% +$51.3K 0.59% 44
2024
Q1
$8.49M Buy
53,690
+1,336
+3% +$213K 0.66% 38
2023
Q4
$8.21M Sell
52,354
-882
-2% -$135K 0.7% 31
2023
Q3
$8.29M Buy
53,236
+10,388
+24% +$1.71M 0.85% 24
2023
Q2
$7.09M Buy
42,848
+6,973
+19% +$1.13M 0.89% 23
2023
Q1
$5.56M Sell
35,875
-2,955
-8% -$477K 0.92% 24
2022
Q4
$6.86M Buy
38,830
+8,086
+26% +$1.4M 1.26% 13
2022
Q3
$5.02M Sell
30,744
-1,631
-5% -$276K 1.23% 15
2022
Q2
$5.75M Buy
32,375
+1,270
+4% +$226K 1.26% 14
2022
Q1
$5.51M Buy
31,105
+1,003
+3% +$171K 1.14% 15
2021
Q4
$5.15M Buy
30,102
+3,047
+11% +$499K 1.1% 16
2021
Q3
$4.37M Sell
27,055
-716
-3% -$122K 1.11% 20
2021
Q2
$4.58M Buy
27,771
+5,559
+25% +$920K 1.25% 17
2021
Q1
$3.65M Buy
22,212
+683
+3% +$111K 1.63% 10
2020
Q4
$3.39M Buy
21,529
+1,244
+6% +$184K 1.65% 9
2020
Q3
$3.02M Buy
20,285
+68
+0.3% +$10.1K 1.68% 10
2020
Q2
$2.84M Buy
20,217
+1,667
+9% +$243K 1.51% 11
2020
Q1
$2.43M Buy
18,550
+5,231
+39% +$742K 1.62% 10
2019
Q4
$1.94M Buy
+13,319
New +$1.81M 1.19% 17

Other funds holding JNJ

Procyon Advisors's JNJ Position: Q2 2026 in Review

Procyon Advisors reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, selling an estimated $174K and leaving 30,495 shares worth $7.74M. The position accounts for 0.33% of the portfolio, ranked #68.

Procyon Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.3M in Q1 2025. 2,158 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Procyon Advisors held 30,495 shares of Johnson & Johnson worth $7.74M as of Q2 2026.
  • Procyon Advisors sold 745 Johnson & Johnson shares in Q2 2026, an estimated $174K.
  • Johnson & Johnson made up 0.33% of Procyon Advisors's portfolio in Q2 2026, its #68 holding.
  • Procyon Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Johnson & Johnson position peaked at $10.3M in Q1 2025.
  • 2,158 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.